Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04769947 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Italian Treatment Free Remission Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 18, 2021 (before its estimated July 8, 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Feb 8, 2022 to Jul 8, 2022
    • Start date changed from estimate of May 2021 to Aug 9, 2021
    v3
  2. Start date: Mar 2021 to May 2021v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigator propose an extension of the previous National, multicentric study, promoting an observational registry, both retrospective and prospective, in order to expand and further characterize the series of Italian patients with Philadelphia-positive, chronic phase CML (CP-CML) who discontinue TKIs in an off-protocol setting. As safety concerns may arise for patients receiving long-term treatments, and due to the growing number of patients discontinuing TKIs in clinical practice, the study aim to collect all available data regarding feasibility and freedom from progression of the cohort of patients.
Trial Details
NCT Number NCT04769947
Lead Sponsor University of Turin, Italy
Conditions
(from sponsor)		 Treatment Free Remission, Chronic Myeloid Leukemia
Related terms Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov